A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea

Schaller, Martin; Kemeny, Lajos; Havlickova, Blanka; Jackson, J. Mark; Ambroziak, Marcin; Lynde, Charles; Gooderham, Melinda; Remenyik, Eva; Del Rosso, James; Weglowska, Jolanta; Chavda, Rajeev; Kerrouche, Nabil; Dirschka, Thomas; Johnson, Sandra

dc.contributor.author	Schaller, Martin
dc.date.accessioned	2020-10-27T06:15:28Z
dc.date.available	2020-10-27T06:15:28Z
dc.date.issued	2020
dc.identifier.issn	0190-9622
dc.identifier.uri	http://hdl.handle.net/10900/108642
dc.language.iso	en	de_DE
dc.publisher	Mosby - Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.jaad.2019.05.063	de_DE
dc.subject.ddc	610	de_DE
dc.title	A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_01891
utue.publikation.seiten	336-343	de_DE
utue.personen.roh	Schaller, Martin
utue.personen.roh	Kemeny, Lajos
utue.personen.roh	Havlickova, Blanka
utue.personen.roh	Jackson, J. Mark
utue.personen.roh	Ambroziak, Marcin
utue.personen.roh	Lynde, Charles
utue.personen.roh	Gooderham, Melinda
utue.personen.roh	Remenyik, Eva
utue.personen.roh	Del Rosso, James
utue.personen.roh	Weglowska, Jolanta
utue.personen.roh	Chavda, Rajeev
utue.personen.roh	Kerrouche, Nabil
utue.personen.roh	Dirschka, Thomas
utue.personen.roh	Johnson, Sandra
dcterms.isPartOf.ZSTitelID	Journal of The American Academy of Dermatology	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	82	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE